Fortville, IN, United States of America

Kristine Kay Kikly

USPTO Granted Patents = 34 

 

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 164(Granted Patents)


Location History:

  • Linfield, PA (US) (1999 - 2007)
  • Fortville, IN (2011)
  • Fortville, IN (US) (2008 - 2012)
  • Spiceland, IN (US) (2015 - 2024)
  • Indianapolis, IN (US) (2024)

Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents

Title: **Kristine Kay Kikly: Innovator in Biopharmaceutical Patents**

Introduction

Kristine Kay Kikly, a prominent inventor based in Fortville, Indiana, has made significant contributions to the field of biopharmaceuticals, holding a total of 34 patents throughout her career. Her work focuses on innovative therapeutic solutions, particularly in the treatment of complex medical conditions.

Latest Patents

Among her recent inventions, two notable patents stand out. The first is for "PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa." This patent provides methods and uses for antibodies targeting ELR+ CXC chemokines specifically aimed at treating this chronic skin condition. Alongside this, she has developed the "Anti-CD11D antibodies and uses thereof," which details antibodies to human CD11d and describes their application in treating central nervous system trauma, including spinal cord injury and traumatic brain injury, as well as addressing systemic inflammatory responses following such injuries.

Career Highlights

Kristine has had a notable career, having worked with renowned companies in the pharmaceutical sector, including SmithKline Beecham Corporation and Eli Lilly and Company. Her experience in these organizations has allowed her to develop and patent cutting-edge biopharmaceutical solutions that address significant health challenges.

Collaborations

Throughout her career, Kristine has collaborated with several talented individuals, notably Catherine Brautigam Beidler and Connie L. Erickson-Miller. These partnerships have contributed to her innovative approach to research and development in her field.

Conclusion

Kristine Kay Kikly's dedication to innovation in biopharmaceuticals is clear through her extensive patent portfolio and collaborations. Her work not only demonstrates her expertise but also her commitment to developing therapies that can significantly improve patient outcomes in challenging medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…